Literature DB >> 24482154

Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease.

Eun-Young Lee1, Paul J Eslinger, Guangwei Du, Lan Kong, Mechelle M Lewis, Xuemei Huang.   

Abstract

BACKGROUND: Olfactory dysfunction is often associated with Parkinson's disease (PD) and can precede characteristic motor symptoms by several years. Olfactory-related cortical atrophy has been reported in PD, although the extent and association between cortical atrophy and olfactory dysfunction have been controversial. The present study examined whether olfactory dysfunction is associated with gray matter (GM) volume in brain regions subserving primary and secondary olfactory processing.
METHODS: High-resolution T1-weighted brain MRIs were acquired from 40 PD without dementia and 40 matched controls along with smell identification scores. Brain volumes were compared using voxel-based morphometry.
RESULTS: Compared to controls, PD patients sustained greater GM loss localized to bilateral piriform cortex (PC) and orbitofrontal cortex (OFC). Reduced olfactory performance in PD was significantly associated with lower GM volumes in PC and OFC.
CONCLUSIONS: Both primary and secondary olfactory cortical atrophy occurred in PD and were associated with olfactory dysfunction.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MRI; Parkinson's disease; olfaction; olfactory cortex; voxel-based morphometry

Mesh:

Year:  2014        PMID: 24482154      PMCID: PMC4116478          DOI: 10.1002/mds.25829

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

Review 1.  Criteria for diagnosing Parkinson's disease.

Authors:  D B Calne; B J Snow; C Lee
Journal:  Ann Neurol       Date:  1992       Impact factor: 10.422

2.  Decreased olfactory bulb volume in idiopathic Parkinson's disease detected by 3.0-tesla magnetic resonance imaging.

Authors:  Stefan Brodoehl; Carsten Klingner; Gerd F Volk; Thomas Bitter; Otto W Witte; Christoph Redecker
Journal:  Mov Disord       Date:  2012-06-21       Impact factor: 10.338

3.  Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study.

Authors:  Toru Baba; Akio Kikuchi; Kazumi Hirayama; Yoshiyuki Nishio; Yoshiyuki Hosokai; Shigenori Kanno; Takafumi Hasegawa; Naoto Sugeno; Masatoshi Konno; Kyoko Suzuki; Shoki Takahashi; Hiroshi Fukuda; Masashi Aoki; Yasuto Itoyama; Etsuro Mori; Atsushi Takeda
Journal:  Brain       Date:  2012-01       Impact factor: 13.501

Review 4.  Anhedonia in Parkinson's disease: a systematic review of the literature.

Authors:  Francesca Assogna; Luca Cravello; Carlo Caltagirone; Gianfranco Spalletta
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

5.  Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson's disease.

Authors:  Xiaoli Wu; Chunshui Yu; Fengmei Fan; Kaiyuan Zhang; Chaozhe Zhu; Tao Wu; Kuncheng Li; Piu Chan
Journal:  Eur Neurol       Date:  2011-08-12       Impact factor: 1.710

Review 6.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

Authors:  Claire L Tomlinson; Rebecca Stowe; Smitaa Patel; Caroline Rick; Richard Gray; Carl E Clarke
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

7.  Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael A Kilbourn; Roger L Albin; Kirk A Frey
Journal:  Brain       Date:  2010-04-22       Impact factor: 13.501

Review 8.  Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach.

Authors:  Katie Hoyles; Jagdish C Sharma
Journal:  J Neurol       Date:  2013-02-03       Impact factor: 4.849

9.  Olfactory hedonic judgment in patients with deficit syndrome schizophrenia.

Authors:  Gregory P Strauss; Daniel N Allen; Sylvia A Ross; Lisa A Duke; Jason Schwartz
Journal:  Schizophr Bull       Date:  2009-02-17       Impact factor: 9.306

10.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

View more
  20 in total

1.  The pattern of gray matter atrophy in Parkinson's disease differs in cortical and subcortical regions.

Authors:  Mechelle M Lewis; Guangwei Du; Eun-Young Lee; Zeinab Nasralah; Nicholas W Sterling; Lijun Zhang; Daymond Wagner; Lan Kong; Alexander I Tröster; Martin Styner; Paul J Eslinger; Richard B Mailman; Xuemei Huang
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

Review 2.  Olfactory dysfunction in dementia.

Authors:  Jorge Alves; Agavni Petrosyan; Rosana Magalhães
Journal:  World J Clin Cases       Date:  2014-11-16       Impact factor: 1.337

3.  Unilateral Choanal Atresia: Indications of Long-Term Olfactory Deficits and Volumetric Brain Changes Postsurgically.

Authors:  Charalampos Georgiopoulos; Martina Postler; Philippe Rombaux; Volker Gudziol; Nasreddin Abolmaali; Thomas Hummel
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2021-11-26       Impact factor: 1.919

Review 4.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

Review 5.  Neuroimaging of Parkinson's disease: Expanding views.

Authors:  Carol P Weingarten; Mark H Sundman; Patrick Hickey; Nan-kuei Chen
Journal:  Neurosci Biobehav Rev       Date:  2015-09-26       Impact factor: 8.989

6.  Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb.

Authors:  Aishwarya S Kulkarni; Maria Del Mar Cortijo; Elizabeth R Roberts; Tamara L Suggs; Heather B Stover; José I Pena-Bravo; Jennifer A Steiner; Kelvin C Luk; Patrik Brundin; Daniel W Wesson
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

7.  Role of disgust proneness in Parkinson's disease: a voxel-based morphometry study.

Authors:  Rottraut Ille; Albert Wabnegger; Petra Schwingenschuh; Petra Katschnig-Winter; Mariella Kögl-Wallner; Karoline Wenzel; Anne Schienle
Journal:  J Int Neuropsychol Soc       Date:  2015-04-24       Impact factor: 2.892

Review 8.  Computational Modelling Approaches on Epigenetic Factors in Neurodegenerative and Autoimmune Diseases and Their Mechanistic Analysis.

Authors:  Afroza Khanam Irin; Alpha Tom Kodamullil; Michaela Gündel; Martin Hofmann-Apitius
Journal:  J Immunol Res       Date:  2015-11-09       Impact factor: 4.818

9.  Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice.

Authors:  Christina Coughlan; Douglas I Walker; Kelly M Lohr; Jason R Richardson; Laura M Saba; W Michael Caudle; Kristofer S Fritz; James R Roede
Journal:  Parkinsons Dis       Date:  2015-08-09

10.  Dopaminergic Therapy Modulates Cortical Perfusion in Parkinson Disease With and Without Dementia According to Arterial Spin Labeled Perfusion Magnetic Resonance Imaging.

Authors:  Wei-Che Lin; Pei-Chin Chen; Yung-Cheng Huang; Nai-Wen Tsai; Hsiu-Ling Chen; Hung-Chen Wang; Tsu-Kung Lin; Kun-Hsien Chou; Meng-Hsiang Chen; Yi-Wen Chen; Cheng-Hsien Lu
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.